The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool
Background Atopic dermatitis (AD) severity is assessed using relatively elaborate scoring systems administered by health care practitioners; modification for parent assessment or self-assessment is limited. For ongoing home-based evaluation of pediatric AD treatment and outcomes, a quick, easy-to-us...
Gespeichert in:
| Veröffentlicht in: | Annals of allergy, asthma, & immunology asthma, & immunology, 2008-11, Vol.101 (5), p.500-507 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 507 |
|---|---|
| container_issue | 5 |
| container_start_page | 500 |
| container_title | Annals of allergy, asthma, & immunology |
| container_volume | 101 |
| creator | Carel, Kirstin, MD Bratton, Donna L., MD Miyazawa, Naomi, PA Gyorkos, Elizabeth, PA Kelsay, Kimberly, MD Bender, Bruce, PhD Strand, Matthew, PhD Atkins, Dan, MD Gelfand, Erwin W., MD Klinnert, Mary D., PhD |
| description | Background Atopic dermatitis (AD) severity is assessed using relatively elaborate scoring systems administered by health care practitioners; modification for parent assessment or self-assessment is limited. For ongoing home-based evaluation of pediatric AD treatment and outcomes, a quick, easy-to-use, parent-administered scoring tool is essential. Objective To evaluate the validity and responsiveness to change of the Atopic Dermatitis Quickscore (ADQ) compared with the established, widely used Scoring Atopic Dermatitis Severity Index (SCORAD). Methods The ADQ was developed for parent report and was validated against the SCORAD. The SCORAD assesses percentage of body surface area involved, intensity of a “representative area,” pruritus, and insomnia. The ADQ assesses involvement and pruritus of 7 body parts. Sixty-eight children entering a pediatric day treatment program for moderate to severe AD were recruited. Skin severity was scored at admission by a physician assistant using the SCORAD and by a parent using the ADQ. Pearson correlations of the 2 scales were assessed. Results The ADQ total score correlates with the SCORAD total score ( r = 0.64, P < .001). The ADQ pruritus score correlates with the SCORAD pruritus score ( r = 0.62, P < .001). Correlation at the end of treatment was also seen for ADQ and SCORAD total and pruritus scores ( r = 0.39, P = .02, and r = 0.66, P < .001, respectively). Responsiveness of both scales to change in skin condition was demonstrated, with significant decreases in total and pruritus scores ( P < .001). Conclusions The parent-administered ADQ takes 5 minutes to complete. Scores from the ADQ and the SCORAD are well correlated and are responsive to changes in skin condition, supporting the validity of the ADQ. |
| doi_str_mv | 10.1016/S1081-1206(10)60289-X |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69869179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S108112061060289X</els_id><sourcerecordid>69869179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-769debe696406d2c15b306cc72de4b0f015971f1d49a345586a006ee630c5aa13</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhiMEoqXwE0C-gNpDYCaJnZgDaNXyJVVCFUXam-W1J-A2sRc7Keq_J9ksVOLSky37mWdG82bZc4TXCCjefENoMMcCxDHCiYCikfn6QXaIvKzyqirFw-n-FznInqR0BQDYiPJxdoASOC-gOsz85U9iqyFsnWFnFHs9uMEldjE6c51MiMSOV2cXJ2_Zje6cnX6DZ6Flmnn6zbY6kh9ybXvnXRookmV6cdk716xx_gcbQuieZo9a3SV6tj-Psu8fP1yefs7Pv376cro6z01VyyGvhbS0ISFFBcIWBvmmBGFMXViqNtACcllji7aSuqw4b4QGEESiBMO1xvIoe7V4tzH8GikNqnfJUNdpT2FMSshGSKzlvSBKjhz4DPIFNDGkFKlV2-h6HW8VgpoTUbtE1Lzu-WmXiFpPdS_2DcZNT_auah_BBLzcAzoZ3bVRe-PSP66AhkMlZ-79wtG0txtHUSXjyBuyLpIZlA3u3lHe_Wcw3RTc1PSabildhTH6KRSFKhUKFsnsQNgZ1uUfq368rA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19515059</pqid></control><display><type>article</type><title>The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Carel, Kirstin, MD ; Bratton, Donna L., MD ; Miyazawa, Naomi, PA ; Gyorkos, Elizabeth, PA ; Kelsay, Kimberly, MD ; Bender, Bruce, PhD ; Strand, Matthew, PhD ; Atkins, Dan, MD ; Gelfand, Erwin W., MD ; Klinnert, Mary D., PhD</creator><creatorcontrib>Carel, Kirstin, MD ; Bratton, Donna L., MD ; Miyazawa, Naomi, PA ; Gyorkos, Elizabeth, PA ; Kelsay, Kimberly, MD ; Bender, Bruce, PhD ; Strand, Matthew, PhD ; Atkins, Dan, MD ; Gelfand, Erwin W., MD ; Klinnert, Mary D., PhD</creatorcontrib><description>Background Atopic dermatitis (AD) severity is assessed using relatively elaborate scoring systems administered by health care practitioners; modification for parent assessment or self-assessment is limited. For ongoing home-based evaluation of pediatric AD treatment and outcomes, a quick, easy-to-use, parent-administered scoring tool is essential. Objective To evaluate the validity and responsiveness to change of the Atopic Dermatitis Quickscore (ADQ) compared with the established, widely used Scoring Atopic Dermatitis Severity Index (SCORAD). Methods The ADQ was developed for parent report and was validated against the SCORAD. The SCORAD assesses percentage of body surface area involved, intensity of a “representative area,” pruritus, and insomnia. The ADQ assesses involvement and pruritus of 7 body parts. Sixty-eight children entering a pediatric day treatment program for moderate to severe AD were recruited. Skin severity was scored at admission by a physician assistant using the SCORAD and by a parent using the ADQ. Pearson correlations of the 2 scales were assessed. Results The ADQ total score correlates with the SCORAD total score ( r = 0.64, P < .001). The ADQ pruritus score correlates with the SCORAD pruritus score ( r = 0.62, P < .001). Correlation at the end of treatment was also seen for ADQ and SCORAD total and pruritus scores ( r = 0.39, P = .02, and r = 0.66, P < .001, respectively). Responsiveness of both scales to change in skin condition was demonstrated, with significant decreases in total and pruritus scores ( P < .001). Conclusions The parent-administered ADQ takes 5 minutes to complete. Scores from the ADQ and the SCORAD are well correlated and are responsive to changes in skin condition, supporting the validity of the ADQ.</description><identifier>ISSN: 1081-1206</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/S1081-1206(10)60289-X</identifier><identifier>PMID: 19055204</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Allergy and Immunology ; Biological and medical sciences ; Child ; Child, Preschool ; Dermatitis, Atopic - diagnosis ; Dermatitis, Atopic - immunology ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Humans ; Infant ; Male ; Medical sciences ; Parents ; Reproducibility of Results ; Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis ; Severity of Illness Index ; Statistics, Nonparametric</subject><ispartof>Annals of allergy, asthma, & immunology, 2008-11, Vol.101 (5), p.500-507</ispartof><rights>American College of Allergy, Asthma & Immunology</rights><rights>2008 American College of Allergy, Asthma & Immunology</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-769debe696406d2c15b306cc72de4b0f015971f1d49a345586a006ee630c5aa13</citedby><cites>FETCH-LOGICAL-c479t-769debe696406d2c15b306cc72de4b0f015971f1d49a345586a006ee630c5aa13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S108112061060289X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20850494$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19055204$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carel, Kirstin, MD</creatorcontrib><creatorcontrib>Bratton, Donna L., MD</creatorcontrib><creatorcontrib>Miyazawa, Naomi, PA</creatorcontrib><creatorcontrib>Gyorkos, Elizabeth, PA</creatorcontrib><creatorcontrib>Kelsay, Kimberly, MD</creatorcontrib><creatorcontrib>Bender, Bruce, PhD</creatorcontrib><creatorcontrib>Strand, Matthew, PhD</creatorcontrib><creatorcontrib>Atkins, Dan, MD</creatorcontrib><creatorcontrib>Gelfand, Erwin W., MD</creatorcontrib><creatorcontrib>Klinnert, Mary D., PhD</creatorcontrib><title>The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool</title><title>Annals of allergy, asthma, & immunology</title><addtitle>Ann Allergy Asthma Immunol</addtitle><description>Background Atopic dermatitis (AD) severity is assessed using relatively elaborate scoring systems administered by health care practitioners; modification for parent assessment or self-assessment is limited. For ongoing home-based evaluation of pediatric AD treatment and outcomes, a quick, easy-to-use, parent-administered scoring tool is essential. Objective To evaluate the validity and responsiveness to change of the Atopic Dermatitis Quickscore (ADQ) compared with the established, widely used Scoring Atopic Dermatitis Severity Index (SCORAD). Methods The ADQ was developed for parent report and was validated against the SCORAD. The SCORAD assesses percentage of body surface area involved, intensity of a “representative area,” pruritus, and insomnia. The ADQ assesses involvement and pruritus of 7 body parts. Sixty-eight children entering a pediatric day treatment program for moderate to severe AD were recruited. Skin severity was scored at admission by a physician assistant using the SCORAD and by a parent using the ADQ. Pearson correlations of the 2 scales were assessed. Results The ADQ total score correlates with the SCORAD total score ( r = 0.64, P < .001). The ADQ pruritus score correlates with the SCORAD pruritus score ( r = 0.62, P < .001). Correlation at the end of treatment was also seen for ADQ and SCORAD total and pruritus scores ( r = 0.39, P = .02, and r = 0.66, P < .001, respectively). Responsiveness of both scales to change in skin condition was demonstrated, with significant decreases in total and pruritus scores ( P < .001). Conclusions The parent-administered ADQ takes 5 minutes to complete. Scores from the ADQ and the SCORAD are well correlated and are responsive to changes in skin condition, supporting the validity of the ADQ.</description><subject>Allergy and Immunology</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Dermatitis, Atopic - diagnosis</subject><subject>Dermatitis, Atopic - immunology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Parents</subject><subject>Reproducibility of Results</subject><subject>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</subject><subject>Severity of Illness Index</subject><subject>Statistics, Nonparametric</subject><issn>1081-1206</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhiMEoqXwE0C-gNpDYCaJnZgDaNXyJVVCFUXam-W1J-A2sRc7Keq_J9ksVOLSky37mWdG82bZc4TXCCjefENoMMcCxDHCiYCikfn6QXaIvKzyqirFw-n-FznInqR0BQDYiPJxdoASOC-gOsz85U9iqyFsnWFnFHs9uMEldjE6c51MiMSOV2cXJ2_Zje6cnX6DZ6Flmnn6zbY6kh9ybXvnXRookmV6cdk716xx_gcbQuieZo9a3SV6tj-Psu8fP1yefs7Pv376cro6z01VyyGvhbS0ISFFBcIWBvmmBGFMXViqNtACcllji7aSuqw4b4QGEESiBMO1xvIoe7V4tzH8GikNqnfJUNdpT2FMSshGSKzlvSBKjhz4DPIFNDGkFKlV2-h6HW8VgpoTUbtE1Lzu-WmXiFpPdS_2DcZNT_auah_BBLzcAzoZ3bVRe-PSP66AhkMlZ-79wtG0txtHUSXjyBuyLpIZlA3u3lHe_Wcw3RTc1PSabildhTH6KRSFKhUKFsnsQNgZ1uUfq368rA</recordid><startdate>20081101</startdate><enddate>20081101</enddate><creator>Carel, Kirstin, MD</creator><creator>Bratton, Donna L., MD</creator><creator>Miyazawa, Naomi, PA</creator><creator>Gyorkos, Elizabeth, PA</creator><creator>Kelsay, Kimberly, MD</creator><creator>Bender, Bruce, PhD</creator><creator>Strand, Matthew, PhD</creator><creator>Atkins, Dan, MD</creator><creator>Gelfand, Erwin W., MD</creator><creator>Klinnert, Mary D., PhD</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20081101</creationdate><title>The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool</title><author>Carel, Kirstin, MD ; Bratton, Donna L., MD ; Miyazawa, Naomi, PA ; Gyorkos, Elizabeth, PA ; Kelsay, Kimberly, MD ; Bender, Bruce, PhD ; Strand, Matthew, PhD ; Atkins, Dan, MD ; Gelfand, Erwin W., MD ; Klinnert, Mary D., PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-769debe696406d2c15b306cc72de4b0f015971f1d49a345586a006ee630c5aa13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Allergy and Immunology</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Dermatitis, Atopic - diagnosis</topic><topic>Dermatitis, Atopic - immunology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Parents</topic><topic>Reproducibility of Results</topic><topic>Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis</topic><topic>Severity of Illness Index</topic><topic>Statistics, Nonparametric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carel, Kirstin, MD</creatorcontrib><creatorcontrib>Bratton, Donna L., MD</creatorcontrib><creatorcontrib>Miyazawa, Naomi, PA</creatorcontrib><creatorcontrib>Gyorkos, Elizabeth, PA</creatorcontrib><creatorcontrib>Kelsay, Kimberly, MD</creatorcontrib><creatorcontrib>Bender, Bruce, PhD</creatorcontrib><creatorcontrib>Strand, Matthew, PhD</creatorcontrib><creatorcontrib>Atkins, Dan, MD</creatorcontrib><creatorcontrib>Gelfand, Erwin W., MD</creatorcontrib><creatorcontrib>Klinnert, Mary D., PhD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, & immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carel, Kirstin, MD</au><au>Bratton, Donna L., MD</au><au>Miyazawa, Naomi, PA</au><au>Gyorkos, Elizabeth, PA</au><au>Kelsay, Kimberly, MD</au><au>Bender, Bruce, PhD</au><au>Strand, Matthew, PhD</au><au>Atkins, Dan, MD</au><au>Gelfand, Erwin W., MD</au><au>Klinnert, Mary D., PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool</atitle><jtitle>Annals of allergy, asthma, & immunology</jtitle><addtitle>Ann Allergy Asthma Immunol</addtitle><date>2008-11-01</date><risdate>2008</risdate><volume>101</volume><issue>5</issue><spage>500</spage><epage>507</epage><pages>500-507</pages><issn>1081-1206</issn><eissn>1534-4436</eissn><abstract>Background Atopic dermatitis (AD) severity is assessed using relatively elaborate scoring systems administered by health care practitioners; modification for parent assessment or self-assessment is limited. For ongoing home-based evaluation of pediatric AD treatment and outcomes, a quick, easy-to-use, parent-administered scoring tool is essential. Objective To evaluate the validity and responsiveness to change of the Atopic Dermatitis Quickscore (ADQ) compared with the established, widely used Scoring Atopic Dermatitis Severity Index (SCORAD). Methods The ADQ was developed for parent report and was validated against the SCORAD. The SCORAD assesses percentage of body surface area involved, intensity of a “representative area,” pruritus, and insomnia. The ADQ assesses involvement and pruritus of 7 body parts. Sixty-eight children entering a pediatric day treatment program for moderate to severe AD were recruited. Skin severity was scored at admission by a physician assistant using the SCORAD and by a parent using the ADQ. Pearson correlations of the 2 scales were assessed. Results The ADQ total score correlates with the SCORAD total score ( r = 0.64, P < .001). The ADQ pruritus score correlates with the SCORAD pruritus score ( r = 0.62, P < .001). Correlation at the end of treatment was also seen for ADQ and SCORAD total and pruritus scores ( r = 0.39, P = .02, and r = 0.66, P < .001, respectively). Responsiveness of both scales to change in skin condition was demonstrated, with significant decreases in total and pruritus scores ( P < .001). Conclusions The parent-administered ADQ takes 5 minutes to complete. Scores from the ADQ and the SCORAD are well correlated and are responsive to changes in skin condition, supporting the validity of the ADQ.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>19055204</pmid><doi>10.1016/S1081-1206(10)60289-X</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1081-1206 |
| ispartof | Annals of allergy, asthma, & immunology, 2008-11, Vol.101 (5), p.500-507 |
| issn | 1081-1206 1534-4436 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69869179 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Allergy and Immunology Biological and medical sciences Child Child, Preschool Dermatitis, Atopic - diagnosis Dermatitis, Atopic - immunology Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Infant Male Medical sciences Parents Reproducibility of Results Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis Severity of Illness Index Statistics, Nonparametric |
| title | The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T10%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Atopic%20Dermatitis%20Quickscore%20(ADQ):%20validation%20of%20a%20new%20parent-administered%20atopic%20dermatitis%20scoring%20tool&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Carel,%20Kirstin,%20MD&rft.date=2008-11-01&rft.volume=101&rft.issue=5&rft.spage=500&rft.epage=507&rft.pages=500-507&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/S1081-1206(10)60289-X&rft_dat=%3Cproquest_cross%3E69869179%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19515059&rft_id=info:pmid/19055204&rft_els_id=S108112061060289X&rfr_iscdi=true |